577 filings
Page 5 of 29
8-K
w2mo8cqjdw8o u98
27 Mar 20
Results of Operations and Financial Condition
7:20am
8-K
19m ho5cdzjnp85
13 Nov 19
Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update
4:20pm
8-K
f0jn sdgp8y72
1 Oct 19
Departure of Directors or Certain Officers
4:06pm
UPLOAD
lsd0ac359lc4daq
22 Aug 19
Letter from SEC
12:00am
8-K
9bx0rqhnvoh aach87c
21 Aug 19
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™Clinical Development
7:05am
CORRESP
jg5 gecwv0zhdm2v
19 Aug 19
Correspondence with SEC
12:00am
UPLOAD
r3sqeocywvla14t3xug
16 Aug 19
Letter from SEC
12:00am
S-8
17k5mhvpze 9rwv4
14 Aug 19
Registration of securities for employees
12:00am
8-K
b2to641 yxdn5
13 Aug 19
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
4:21pm
8-K
97t3jrr
15 Jul 19
Completion of Acquisition or Disposition of Assets
7:22am
8-K
d7vf5dr7
9 Jul 19
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
7:58am
8-K
t3fjbvm6mq22678 st
21 Jun 19
Departure of Directors or Certain Officers
4:47pm
8-K
7icyhvnax7cx25
12 Jun 19
Altimmune Appoints Will Brown as Chief Financial Officer
4:02pm
8-K
fybjjme
7 Jun 19
Departure of Directors or Certain Officers
4:02pm
8-K
w8tdd si0
14 May 19
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
4:15pm